Related references
Note: Only part of the references are listed.Human dendritic cells in cancer
Egle Kvedaraite et al.
SCIENCE IMMUNOLOGY (2022)
Allogeneic Vγ9Vδ2 T-cell immunotherapy exhibits promising clinical safety and prolongs the survival of patients with late-stage lung or liver cancer
Yan Xu et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2021)
Anti-inflammatory Effects of Empagliflozin and Gemigliptin on LPS-Stimulated Macrophage via the IKK/NF-κB, MKK7/JNK, and JAK2/STAT1 Signalling Pathways
Nami Lee et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2021)
Cancer immunotherapy with γδ T cells: many paths ahead of us
Dieter Kabelitz et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells
Daisuke Okuno et al.
FRONTIERS IN IMMUNOLOGY (2020)
Antigen Cross-Presentation by Macrophages
Elke M. Muntjewerff et al.
FRONTIERS IN IMMUNOLOGY (2020)
Tumor microenvironment-related dendritic cell deficiency: a target to enhance tumor immunotherapy
Shan Zhu et al.
PHARMACOLOGICAL RESEARCH (2020)
Antigen processing and presentation in cancer immunotherapy
Maxwell Y. Lee et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Increased effector γδ T cells with enhanced cytokine production are associated with inflammatory abnormalities in severe hand, foot, and mouth disease
Yanxi Shen et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2019)
Roles of Extracellular HSPs as Biomarkers in Immune Surveillance and Immune Evasion
Eman A. Taha et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Occurrence of the potent mutagens 2-nitrobenzanthrone and 3-nitrobenzanthrone in fine airborne particles
Aldenor G. Santos et al.
SCIENTIFIC REPORTS (2019)
γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer
Bruno Silva-Santos et al.
NATURE REVIEWS CANCER (2019)
Mutation analysis of the EBV-lymphoblastoid cell line cautions their use as antigen-presenting cells
Qin Tan et al.
IMMUNOLOGY AND CELL BIOLOGY (2018)
Human T Cell Development, Localization, and Function throughout Life
Brahma V. Kumar et al.
IMMUNITY (2018)
Mycobacterium tuberculosis PPE60 antigen drives Th1/Th17 responses via Toll-like receptor 2-dependent maturation of dendritic cells
Haibo Su et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Molecular Determinants of Target Cell Recognition by Human γδ T Cells
Andre E. Simoes et al.
FRONTIERS IN IMMUNOLOGY (2018)
Absence of Tumor Necrosis Factor Supports Alternative Activation of Macrophages in the Liver after Infection with Leishmania major
Shanshan Hu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivo
Zhenzhen Chen et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Dendritic Cells and CD8 T Cell Immunity in Tumor Microenvironment
Chunmei Fu et al.
FRONTIERS IN IMMUNOLOGY (2018)
Antigen cross-presentation and T-cell cross-priming in cancer immunology and immunotherapy
A. R. Sanchez-Paulete et al.
ANNALS OF ONCOLOGY (2017)
Antigen Cross-Presentation and Heat Shock Protein-Based Vaccines
Katerina Zachova et al.
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS (2016)
Myeloid molecular characteristics of human γδ T cells support their acquisition of tumor antigen-presenting capacity
Masato Muto et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2015)
Heat shock protein 90 inhibition abrogates TLR4-mediated NF-κB activity and reduces renal ischemia-reperfusion injury
Stephen O'Neill et al.
SCIENTIFIC REPORTS (2015)
Porous Silicon Microparticle Potentiates Anti-Tumor Immunity by Enhancing Cross-Presentation and Inducing Type I Interferon Response
Xiaojun Xia et al.
CELL REPORTS (2015)
High-throughput epitope discovery reveals frequent recognition of neo-antigens by CD4(+) T cells in human melanoma
Carsten Linnemann et al.
NATURE MEDICINE (2015)
Combination Immunotherapy after ASCT for Multiple Myeloma Using MAGE-A3/Poly-ICLC Immunizations Followed by Adoptive Transfer of Vaccine-Primed and Costimulated Autologous T Cells
Aaron P. Rapoport et al.
CLINICAL CANCER RESEARCH (2014)
Molecular Mechanisms of TLR2-Mediated Antigen Cross-Presentation in Dendritic Cells
Kuan-Yin Shen et al.
JOURNAL OF IMMUNOLOGY (2014)
Tumor-Activated TCRγδ+ T Cells from Gastric Cancer Patients Induce the Antitumor Immune Response of TCRαβ+ T Cells via Their Antigen-Presenting Cell-Like Effects
Chaoming Mao et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2014)
Insights into vie relationship between toll like receptors and gamma delta T cell responses
Asif Amin Dar et al.
FRONTIERS IN IMMUNOLOGY (2014)
EBV-transformed lymphoblastoid cell lines as vaccines against cancer testis antigen-positive tumors
Frank Neumann et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2013)
What lessons can be learned from γδ T cell-based cancer immunotherapy trials?
Jean-Jacques Fournie et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
HLA-restricted presentation of WT1 tumor antigen in B-lymphoblastoid cell lines established using a maxi-EBV system
T. Kanda et al.
CANCER GENE THERAPY (2012)
IL-21 enhances the potential of human γδ T cells to provide B-cell help
Raj R. Bansal et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2012)
The role of heat shock proteins in antigen cross presentation
Ayesha Murshid et al.
FRONTIERS IN IMMUNOLOGY (2012)
Heat shock protein 90 (HSP90) contributes to cytosolic translocation of extracellular antigen for cross-presentation by dendritic cells
Takashi Imai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Prolonged antigen survival and cytosolic export in cross-presenting human γδ T cells
Simone Meuter et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Cross-presenting human γδ T cells induce robust CD8+ αβ T cell responses
Marlene Brandes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Autologous designer antigen-presenting cells by gene modification of T lymphocyte blasts with IL-7 and IL-12
Aaron E. Foster et al.
JOURNAL OF IMMUNOTHERAPY (2007)
CXCR5 identifies a subset of Vγ9Vδ2 T cells which secrete IL-4 and IL-10 and help B cells for antibody production
Nadia Caccamo et al.
JOURNAL OF IMMUNOLOGY (2006)
The N-terminal fragment of GRP94 is sufficient for peptide presentation via professional antigen-presenting cells
Chhanda Biswas et al.
INTERNATIONAL IMMUNOLOGY (2006)
Robust expansion of viral antigen-specific CD4+ and CD8+ T cells for adoptive T cell therapy using gene-modified activated T cells as antigen presenting cells
Jan Joseph Melenhorst et al.
JOURNAL OF IMMUNOTHERAPY (2006)
Analysis of transgene-specific immune responses that limit the in vivo persistence of adoptively transferred HSV-TK-modified donor T cells after allogeneic hematopoietic cell transplantation
C Berger et al.
BLOOD (2006)
Professional antigen-presentation function by human γδ T cells
M Brandes et al.
SCIENCE (2005)
Flexible migration program regulates γδ T-cell involvement in humoral immunity
M Brandes et al.
BLOOD (2003)
Use of spontaneous Epstein-Barr virus-lymphoblastoid cell lines genetically modified to express tumor antigen as cancer vaccines:: Mutated p21 ras oncogene in pancreatic carcinoma as a model
B Kubuschok et al.
HUMAN GENE THERAPY (2002)
B lymphoblastoid cell lines as efficient APC to elicit CD8+ T cell responses against a cytomegalovirus antigen
Q Sun et al.
JOURNAL OF IMMUNOLOGY (2000)
Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression
ZX Zhang et al.
NATURE MEDICINE (2000)
Share Paper
